サマリー

瘢痕は皮膚よりも高い位置にあり、隆起したままである。過剰な繊維組織は、ケロイドまたは肥厚性瘢痕のいずれかに分類される。KischerとBrodyは、肥厚性瘢痕とケロイドの識別構造単位はコラーゲン結節であると発表した。

市場分析と洞察。世界および中国の肥大性瘢痕およびケロイドの治療市場
当レポートでは、世界および中国の肥厚性瘢痕およびケロイド状瘢痕治療市場に焦点を当てています。
2020年の肥大性・ケロイド性瘢痕療法の世界市場規模はXX百万米ドルで、2021年から2027年の間にXX％のCAGRで、2027年末にはXX百万米ドルに達すると予測されています。中国では、Hypertrophic and Keloid Scar Therapyの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予測されています。

世界の肥大性・ケロイド性瘢痕治療の範囲と市場規模
肥大性・ケロイド性瘢痕療法市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のHypertrophic and Keloid Scar Therapy市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2016年から2027年までの地域（国）別、タイプ別、アプリケーション別の売上高と予測に焦点を当てています。
中国市場については、2016-2027年の肥大性瘢痕およびケロイド状瘢痕療法の市場規模を、プレイヤー別、タイプ別、アプリケーション別に分析しています。主要プレイヤーには、中国で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
局所製品
レーザー製品
インジェクタブル
その他

用途別セグメント
病院
クリニック
その他

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

会社別
スミス・アンド・ネフュー
エナルタス
Merz
Lumenis
ソノマ・ファーマシューティカルズ
シノシュア
スカーヒール
メンリッケ・ヘルス（Mölnlycke Health
ペリゴ
ニューメディカルテクノロジー
サネバ・メディカル
パシフィックワールド

ページTOPに戻る

目次

1 Study Coverage
1.1 Hypertrophic and Keloid Scar Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Hypertrophic and Keloid Scar Therapy Market Size Growth Rate by Type
1.2.2 Topical Products
1.2.3 Laser Products
1.2.4 Injectable
1.2.5 Others
1.3 Market by Application
1.3.1 Global Hypertrophic and Keloid Scar Therapy Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Hypertrophic and Keloid Scar Therapy Market Size, Estimates and Forecasts
2.1.1 Global Hypertrophic and Keloid Scar Therapy Revenue 2016-2027
2.1.2 Global Hypertrophic and Keloid Scar Therapy Sales 2016-2027
2.2 Global Hypertrophic and Keloid Scar Therapy, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Hypertrophic and Keloid Scar Therapy Historical Market Size by Region (2016-2021)
2.3.1 Global Hypertrophic and Keloid Scar Therapy Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Hypertrophic and Keloid Scar Therapy Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Hypertrophic and Keloid Scar Therapy Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Hypertrophic and Keloid Scar Therapy Sales Forecast by Region (2022-2027)
2.4.2 Global Hypertrophic and Keloid Scar Therapy Revenue Forecast by Region (2022-2027)

3 Global Hypertrophic and Keloid Scar Therapy Competitor Landscape by Players
3.1 Global Top Hypertrophic and Keloid Scar Therapy Manufacturers by Sales
3.1.1 Global Hypertrophic and Keloid Scar Therapy Sales by Manufacturer (2016-2021)
3.1.2 Global Hypertrophic and Keloid Scar Therapy Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Hypertrophic and Keloid Scar Therapy Manufacturers by Revenue
3.2.1 Key Hypertrophic and Keloid Scar Therapy Manufacturers Covered: Ranking by Revenue
3.2.2 Global Hypertrophic and Keloid Scar Therapy Revenue by Manufacturers (2016-2021)
3.2.3 Global Hypertrophic and Keloid Scar Therapy Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hypertrophic and Keloid Scar Therapy Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Hypertrophic and Keloid Scar Therapy Revenue in 2020
3.2.6 Global Hypertrophic and Keloid Scar Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hypertrophic and Keloid Scar Therapy Price by Manufacturers
3.4 Global Hypertrophic and Keloid Scar Therapy Manufacturing Base Distribution, Product Types
3.4.1 Hypertrophic and Keloid Scar Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hypertrophic and Keloid Scar Therapy Product Type
3.4.3 Date of International Manufacturers Enter into Hypertrophic and Keloid Scar Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Hypertrophic and Keloid Scar Therapy Market Size by Type (2016-2021)
4.1.1 Global Hypertrophic and Keloid Scar Therapy Sales by Type (2016-2021)
4.1.2 Global Hypertrophic and Keloid Scar Therapy Revenue by Type (2016-2021)
4.1.3 Hypertrophic and Keloid Scar Therapy Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Hypertrophic and Keloid Scar Therapy Market Size Forecast by Type (2022-2027)
4.2.1 Global Hypertrophic and Keloid Scar Therapy Sales Forecast by Type (2022-2027)
4.2.2 Global Hypertrophic and Keloid Scar Therapy Revenue Forecast by Type (2022-2027)
4.2.3 Hypertrophic and Keloid Scar Therapy Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Hypertrophic and Keloid Scar Therapy Market Size by Application (2016-2021)
5.1.1 Global Hypertrophic and Keloid Scar Therapy Sales by Application (2016-2021)
5.1.2 Global Hypertrophic and Keloid Scar Therapy Revenue by Application (2016-2021)
5.1.3 Hypertrophic and Keloid Scar Therapy Price by Application (2016-2021)
5.2 Hypertrophic and Keloid Scar Therapy Market Size Forecast by Application (2022-2027)
5.2.1 Global Hypertrophic and Keloid Scar Therapy Sales Forecast by Application (2022-2027)
5.2.2 Global Hypertrophic and Keloid Scar Therapy Revenue Forecast by Application (2022-2027)
5.2.3 Global Hypertrophic and Keloid Scar Therapy Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Hypertrophic and Keloid Scar Therapy Market Size YoY Growth 2016-2027
6.1.1 China Hypertrophic and Keloid Scar Therapy Sales YoY Growth 2016-2027
6.1.2 China Hypertrophic and Keloid Scar Therapy Revenue YoY Growth 2016-2027
6.1.3 China Hypertrophic and Keloid Scar Therapy Market Share in Global Market 2016-2027
6.2 China Hypertrophic and Keloid Scar Therapy Market Size by Players (International and Local Players)
6.2.1 China Top Hypertrophic and Keloid Scar Therapy Players by Sales (2016-2021)
6.2.2 China Top Hypertrophic and Keloid Scar Therapy Players by Revenue (2016-2021)
6.3 China Hypertrophic and Keloid Scar Therapy Historic Market Review by Type (2016-2021)
6.3.1 China Hypertrophic and Keloid Scar Therapy Sales Market Share by Type (2016-2021)
6.3.2 China Hypertrophic and Keloid Scar Therapy Revenue Market Share by Type (2016-2021)
6.3.3 China Hypertrophic and Keloid Scar Therapy Price by Type (2016-2021)
6.4 China Hypertrophic and Keloid Scar Therapy Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Hypertrophic and Keloid Scar Therapy Sales Forecast by Type (2022-2027)
6.4.2 China Hypertrophic and Keloid Scar Therapy Revenue Forecast by Type (2022-2027)
6.4.3 China Hypertrophic and Keloid Scar Therapy Price Forecast by Type (2022-2027)
6.5 China Hypertrophic and Keloid Scar Therapy Historic Market Review by Application (2016-2021)
6.5.1 China Hypertrophic and Keloid Scar Therapy Sales Market Share by Application (2016-2021)
6.5.2 China Hypertrophic and Keloid Scar Therapy Revenue Market Share by Application (2016-2021)
6.5.3 China Hypertrophic and Keloid Scar Therapy Price by Application (2016-2021)
6.6 China Hypertrophic and Keloid Scar Therapy Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Hypertrophic and Keloid Scar Therapy Sales Forecast by Application (2022-2027)
6.6.2 China Hypertrophic and Keloid Scar Therapy Revenue Forecast by Application (2022-2027)
6.6.3 China Hypertrophic and Keloid Scar Therapy Price Forecast by Application (2022-2027)

7 North America
7.1 North America Hypertrophic and Keloid Scar Therapy Market Size YoY Growth 2016-2027
7.2 North America Hypertrophic and Keloid Scar Therapy Market Facts & Figures by Country
7.2.1 North America Hypertrophic and Keloid Scar Therapy Sales by Country (2016-2021)
7.2.2 North America Hypertrophic and Keloid Scar Therapy Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Hypertrophic and Keloid Scar Therapy Market Size YoY Growth 2016-2027
8.2 Asia Pacific Hypertrophic and Keloid Scar Therapy Market Facts & Figures by Region
8.2.1 Asia Pacific Hypertrophic and Keloid Scar Therapy Sales by Region (2016-2021)
8.2.2 Asia Pacific Hypertrophic and Keloid Scar Therapy Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Hypertrophic and Keloid Scar Therapy Market Size YoY Growth 2016-2027
9.2 Europe Hypertrophic and Keloid Scar Therapy Market Facts & Figures by Country
9.2.1 Europe Hypertrophic and Keloid Scar Therapy Sales by Country (2016-2021)
9.2.2 Europe Hypertrophic and Keloid Scar Therapy Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Hypertrophic and Keloid Scar Therapy Market Size YoY Growth 2016-2027
10.2 Latin America Hypertrophic and Keloid Scar Therapy Market Facts & Figures by Country
10.2.1 Latin America Hypertrophic and Keloid Scar Therapy Sales by Country (2016-2021)
10.2.2 Latin America Hypertrophic and Keloid Scar Therapy Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Hypertrophic and Keloid Scar Therapy Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Hypertrophic and Keloid Scar Therapy Market Facts & Figures by Country
11.2.1 Middle East and Africa Hypertrophic and Keloid Scar Therapy Sales by Country (2016-2021)
11.2.2 Middle East and Africa Hypertrophic and Keloid Scar Therapy Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Smith & Nephew
12.1.1 Smith & Nephew Corporation Information
12.1.2 Smith & Nephew Description and Business Overview
12.1.3 Smith & Nephew Hypertrophic and Keloid Scar Therapy Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Smith & Nephew Hypertrophic and Keloid Scar Therapy Products Offered
12.1.5 Smith & Nephew Recent Development
12.2 Enaltus
12.2.1 Enaltus Corporation Information
12.2.2 Enaltus Description and Business Overview
12.2.3 Enaltus Hypertrophic and Keloid Scar Therapy Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Enaltus Hypertrophic and Keloid Scar Therapy Products Offered
12.2.5 Enaltus Recent Development
12.3 Merz
12.3.1 Merz Corporation Information
12.3.2 Merz Description and Business Overview
12.3.3 Merz Hypertrophic and Keloid Scar Therapy Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merz Hypertrophic and Keloid Scar Therapy Products Offered
12.3.5 Merz Recent Development
12.4 Lumenis
12.4.1 Lumenis Corporation Information
12.4.2 Lumenis Description and Business Overview
12.4.3 Lumenis Hypertrophic and Keloid Scar Therapy Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Lumenis Hypertrophic and Keloid Scar Therapy Products Offered
12.4.5 Lumenis Recent Development
12.5 Sonoma Pharmaceuticals
12.5.1 Sonoma Pharmaceuticals Corporation Information
12.5.2 Sonoma Pharmaceuticals Description and Business Overview
12.5.3 Sonoma Pharmaceuticals Hypertrophic and Keloid Scar Therapy Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sonoma Pharmaceuticals Hypertrophic and Keloid Scar Therapy Products Offered
12.5.5 Sonoma Pharmaceuticals Recent Development
12.6 Cynosure
12.6.1 Cynosure Corporation Information
12.6.2 Cynosure Description and Business Overview
12.6.3 Cynosure Hypertrophic and Keloid Scar Therapy Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Cynosure Hypertrophic and Keloid Scar Therapy Products Offered
12.6.5 Cynosure Recent Development
12.7 Scar Heal
12.7.1 Scar Heal Corporation Information
12.7.2 Scar Heal Description and Business Overview
12.7.3 Scar Heal Hypertrophic and Keloid Scar Therapy Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Scar Heal Hypertrophic and Keloid Scar Therapy Products Offered
12.7.5 Scar Heal Recent Development
12.8 Mölnlycke Health
12.8.1 Mölnlycke Health Corporation Information
12.8.2 Mölnlycke Health Description and Business Overview
12.8.3 Mölnlycke Health Hypertrophic and Keloid Scar Therapy Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Mölnlycke Health Hypertrophic and Keloid Scar Therapy Products Offered
12.8.5 Mölnlycke Health Recent Development
12.9 Perrigo
12.9.1 Perrigo Corporation Information
12.9.2 Perrigo Description and Business Overview
12.9.3 Perrigo Hypertrophic and Keloid Scar Therapy Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Perrigo Hypertrophic and Keloid Scar Therapy Products Offered
12.9.5 Perrigo Recent Development
12.10 NewMedical Technology
12.10.1 NewMedical Technology Corporation Information
12.10.2 NewMedical Technology Description and Business Overview
12.10.3 NewMedical Technology Hypertrophic and Keloid Scar Therapy Sales, Revenue and Gross Margin (2016-2021)
12.10.4 NewMedical Technology Hypertrophic and Keloid Scar Therapy Products Offered
12.10.5 NewMedical Technology Recent Development
12.11 Smith & Nephew
12.11.1 Smith & Nephew Corporation Information
12.11.2 Smith & Nephew Description and Business Overview
12.11.3 Smith & Nephew Hypertrophic and Keloid Scar Therapy Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Smith & Nephew Hypertrophic and Keloid Scar Therapy Products Offered
12.11.5 Smith & Nephew Recent Development
12.12 Pacific World
12.12.1 Pacific World Corporation Information
12.12.2 Pacific World Description and Business Overview
12.12.3 Pacific World Hypertrophic and Keloid Scar Therapy Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Pacific World Products Offered
12.12.5 Pacific World Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Hypertrophic and Keloid Scar Therapy Industry Trends
13.2 Hypertrophic and Keloid Scar Therapy Market Drivers
13.3 Hypertrophic and Keloid Scar Therapy Market Challenges
13.4 Hypertrophic and Keloid Scar Therapy Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hypertrophic and Keloid Scar Therapy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer